Evidence map›Paper›PMID 41328200›Full record

ArticleClinical case reports2025

Diagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report.

Mahsa Malekian, Vahide Sadra, Amir Bahrami, Javad Jalili, Hamidreza Ashayeri

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahsa MalekianEndocrine Research Center Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-5195-3405
Vahide SadraEndocrine Research Center Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0003-3724-209X
Amir BahramiEndocrine Research Center Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-4735-1196
Javad JaliliRadiology Department, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0003-0588-2287
Hamidreza AshayeriStudent Research Committee Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-2593-9810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a significant comorbidity in the New World, and its prevalence is rising. Around 5%-10% of cases with hypertension have secondary hypertension. Adrenal gland disease is among the common causes of secondary hypertension. We present a 57-year-old male with uncontrolled hypertension and a history of intracranial hemorrhage. The lab evaluation of the patient revealed a K+ of 3.8 mEq/L, Na + of 138 mEq/L, Renin of 2.6 mIU/L, Aldosterone of 47.3 ng/dL, consistent with primary hyperaldosteronism (PHA). The patient's abdominal computed tomography (CT) revealed an adrenal mass measuring 21 mm in the right adrenal gland. However, the adrenal-vein sampling showed that the mass is probably not the source of aldosterone excess, and a possible diagnosis of adrenal hyperplasia was made. To investigate the adrenal incidentaloma, the 1 mg overnight dexamethasone suppression test was performed. The 8 a.m. cortisol and ACTH levels were reported to be 5 microg/dL and 3.2 pg/mL, and a diagnosis of mild autonomous hypercortisolism was also made. CT is not an accurate method to differentiate between an adrenal-producing adenoma and bilateral idiopathic adrenal hyperplasia. Even in cases where a visible mass is detected on CT, patients aged 35 or older need to be evaluated for the cause of PHA.

Indexed as

adrenal incidentalomabilateral idiopathic hyperplasiamild autonomous hypercortisolismprimary aldosteronismsecondary hypertension

Identifiers

PMID41328200
PMCPMC12665135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.